Rheumatology Vol. 43 No. 9 © British Society for Rheumatology 2004; all rights reserved
Letter to the Editor |
Pregnancy in a rheumatoid arthritis patient on infliximab and methotrexate
Rheumatology, Leicester Royal Infirmary, Leicester and 1 Schering Plough, UK
Correspondence to: A. J. Kinder. E-mail: alisonkinder@dsl.pipex.com
| The first 10% of the full text of this article appears below. |
SIR, A lady was diagnosed with rheumatoid arthritis at the age of 29. She was initially treated with sulphasalazine (3 g/day) and then azathioprine (eventually 250 mg/day) was added. This failed to control her disease, so hydroxychloroquine (400 mg/day) was added. On this combination of drugs (with 5 mg prednisolone and diclofenac 150 mg/day) her disease appeared to be coming under control.
At this point the patient decided she would like to try for a baby. The hydroxychloroquine and sulphasalazine were stopped and the prednisolone was
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Parikh and R. Wong Video phone diagnosis of 'funny turns' Age Ageing, March 1, 2007; 36(2): 234 - 234. [Full Text] [PDF] |
||||
![]() |
F. Pucino Jr., P. T. Harbus, and R. Goldbach-Mansky Use of biologics in rheumatoid arthritis: Where are we going? Am. J. Health Syst. Pharm., September 15, 2006; 63(18 Suppl 4): S19 - S41. [Abstract] [Full Text] [PDF] |
||||

